Bogavac-Stanojevic, Natasa <br/><br/>
Biomarkers for Major Depressive Disorder: Economic Considerations.  [electronic resource] 

 -  Drug development research  11 2016 
 - 374-378 p.  digital 
<br/><br/> Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-2299 
<br/><br/><label>Standard No.: </label>10.1002/ddr.21330  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antidepressive Agents--economics<br/>Biomarkers--metabolism<br/>Cost-Benefit Analysis<br/>Depressive Disorder, Major--drug therapy<br/>Humans<br/>Models, Economic<br/>Quality of Life<br/>Sensitivity and Specificity<br/>Selective Serotonin Reuptake Inhibitors--economics